Rekombinanter IL12B (Briakinumab Biosimilar) Antikörper
Kurzübersicht für Rekombinanter IL12B (Briakinumab Biosimilar) Antikörper (ABIN7543060)
Target
Antikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- Anti-IL-12/23 [ABT-874 (Briakinumab)], Human IgG1, lambda
-
Spezifität
- Binds to human IL12 and IL23 via IL-12/23p40.
-
Produktmerkmale
-
Original Species of Ab: Human
Original Format of Ab: IgG1
-
Aufreinigung
- Protein A affinity purified
-
Immunogen
- This antibody was generated by phage display technology.
-
Isotyp
- IgG1 lambda
-
-
-
-
Applikationshinweise
- This antibody binds to and neutralises human IL12 and IL23.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % Proclin 300.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
-
- IL12B (Briakinumab Biosimilar)
-
Substanzklasse
- Biosimilar
-
Hintergrund
- IL-12p40, Interleukin 12, Interleukin 23, IL12, IL23, IL-12, IL-23
-
UniProt
- P29460
Target
-